ArticleFrontiers in oncology2022
FAIM2 is a potential pan-cancer biomarker for prognosis and immune infiltration.
Jiayang Cai et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
8 papers cite it
this paperpooled itcites it
ArticleFrontiers in oncology2022
Jiayang Cai et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.